We were delighted to talk with Dr Rebecca Bascom (Penn State Hershey Medical Center, Hershey, PA, US) around her study investigating the use of MN-001 in patients with idiopathic pulmonary fibrosis.
‘A Single-Center, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of MN-001 (Tipelukast) in Subjects with Idiopathic Pulmonary Fibrosis.‘ was presented at ATS 2021 International Conference, 14-19 May, 2021.
- Could you give us a brief overview of the challenges in treating idiopathic pulmonary fibrosis (IPF) and how therapy has evolved in recent years? (0:15)
- What is tipelukast and what is its mechanism of action? (0:50)
- What were the aims and design of the first clinical trial of tipelukast? (1:25)
- What were the efficacy and safety findings of the study after 12 months? (2:02)
- What will be the next steps for tipelukast in this indication? (2:39)
Disclosures: Rebecca Bascom has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.
Filmed as a highlight of ATS 2021 (Virtual).
Share this Video
Related Videos In Idiopathic pulmonary fibrosis
Junelle Speller – The Pulmonary Fibrosis Foundation Community Registry
The Pulmonary Fibrosis Foundation (PFF) Registry is collecting data from patients with pulmonary fibrosis (PF) or interstitial lung disease (ILD), lung transplant recipients who have had PF or ILD as well as caregivers and family members of patients to help advance medical research. It was a pleasure to talk with PFF Vice President, Junelle Speller […]
Junelle Speller: Pulmonary Fibrosis Foundation – Unmet Needs in Pulmonary Fibrosis and Interstitial Lung Disease
The Pulmonary Fibrosis Foundation (PFF) Registry is collecting data from patients with pulmonary fibrosis (PF) or interstitial lung disease (ILD), lung transplant recipients who have had PF or ILD as well as caregivers and family members of patients to help advance medical research. touchRESPIRATORY were delighted to talk to PFF Vice President, Junelle Speller around […]
Bill Schmidt: Pulmonary Fibrosis Foundation – Pulmonary Fibrosis Awareness Month
touchRESPIRATORY were delighted to talk with Bill Schmidt, President and CEO of the Pulmonary Fibrosis Foundation (PFF) around the goals of the Pulmonary Fibrosis Awareness Month taking place over September, this year’s theme “Here for Each Other” and the importance of awareness and reducing misconceptions around pulmonary fibrosis. Questions What are the goals of the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!